title: Inhibition of mitosis in PtK2 cells by CAPP1-calmodulin.
abstract: Various indirect evidence has indicated that calcium ions and the calcium-binding regulator protein, calmodulin, may regulate mitosis in higher eukaryotes. We have used the competitive antagonist, CAPP1-calmodulin, to antagonize intracellular calmodulin and test the hypothesis that calmodulin serves as a regulator of mitosis. We find that CAPP1-calmodulin inhibits the transit of cells through metaphase at estimated intracellular concentrations up to that of native calmodulin; beyond that level, the inhibition of mitosis vanishes. The membrane-permeant anticalmodulin agents, W7 and calmidazolium, also inhibit the progress of cells through metaphase. The similarity of the inhibitory curves for CAPP1-calmodulin, W7, and calmidazolium suggests that all these agents inhibit mitosis by antagonizing intracellular calmodulin. In order to test whether this inhibition of metaphase transit is due to an effect of the agents on intracellular free calcium, we used the calcium indicator Fura-2 to measure intracellular calcium levels after CAPP1-calmodulin injection or during calmidazolium treatment. We found that, while intracellular calcium levels are modestly elevated during calmidazolium treatment, they were unaffected by CAPP1-calmodulin, a result suggesting that mitosis inhibition was not due to an effect on intracellular free calcium. The reasons for the anomalous dose-response behavior of these drugs are not known; however, the behavior of cells at drug levels below the point of anomaly supports the hypothesis that calmodulin acts as a regulator of mitosis in these cells.
authors.affiliation: Department of Zoology, University of Georgia, Athens 30602.
authors.forename: C H
authors.initials: CH
authors.lastname: Keith
authors.forename: D E
authors.initials: DE
authors.lastname: Lin
authors.forename: B H
authors.initials: BH
authors.lastname: Parsons
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D002118:Calcium / Q000032:analysis; D002147:Calmodulin / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000494:pharmacology; D002460:Cell Line; D002478:Cells, Cultured; D003599:Cytoskeleton / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D007093:Imidazoles / Q000494:pharmacology; D008938:Mitosis / Q000187:drug effects*; D010640:Phenothiazines / Q000494:pharmacology*; D013449:Sulfonamides / Q000494:pharmacology
chemical_list: D002147:Calmodulin; D007093:Imidazoles; D010640:Phenothiazines; D013449:Sulfonamides; C046036:phenothiazine-calmodulin complex; C031938:calmidazolium; C017967:W 7; D002118:Calcium